ALFA FinderBSE filing, NSE: CMMHOSP. Summary written from the filing by ALFA Finder's alert engine.
Chennai Meenakshi Multispeciality Hospital Ltd: key numbers
- Share price
- ₹35.80
- Market cap
- ₹26.74 Cr
- Revenue (annual)
- ₹37.04 Cr
- Net profit (annual)
- ₹-1.12 Cr
- P/E (TTM)
- -31.3×Sector 55.1×
- Promoter holding
- 57.10%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Chennai Meenakshi Multispeciality Hospital Ltd
All →Chennai Meenakshi Multispeciality Hospital Legal & Regulatory
Chennai Meenakshi Multispeciality Hospital disclosed a 10 November 2026 court order impleading co-owners in an eviction petition. Annexure states no immediate quantifiable financial impact.
Chennai Meenakshi Multispeciality Hospital Q2 FY27 Results: Net Loss of ₹0.3 Cr
Chennai Meenakshi Multispeciality Hospital Ltd reported revenue from operations of ₹8.6 Cr (-9.5% YoY) and a net loss of ₹0.3 Cr for Q2 FY27.
- Key figure
- Net loss ₹0.3 Cr
Chennai Meenakshi Multispeciality Hospital Other Announcement
Chennai Meenakshi Multispeciality Hospital's quarterly shareholding pattern shows promoters holding 57.10%. The routine filing reports no corporate action or event value.
Chennai Meenakshi Multispeciality Hospital Board Meeting Date
Chennai Meenakshi Multispeciality Hospital will hold a board meeting on 2 November 2026 to consider quarterly and half-year unaudited results. Trading window remains closed from 1 October until 48 hours after results.
Chennai Meenakshi Multispeciality Hospital Other Announcement
Quarterly shareholding pattern for the period ended September 30, 2026, filed in compliance with SEBI Regulation 31(1)(b).
Chennai Meenakshi Multispeciality Hospital Board Meeting Outcome
Chennai Meenakshi Multispeciality Hospital Limited has reconstituted its Audit Committee and Stakeholders Relationship Committee following the recent cessation of certain directors from the Board.
Other other announcement announcements
All →Religare Enterprises Other Announcement
Religare Enterprises filed CARE Ratings' monitoring agency report for the quarter ended September 30, 2026, on its Rs 1,500 crore preferential warrant issue. The report states proceeds were used per the offer document with no deviation.
Optivalue Tek Consulting Other Announcement
Optivalue Tek filed Acuité's half-yearly monitoring report on IPO proceeds for H1 FY2026-27. No deviation from the offer objects was observed.
5Paisa Capital Other Announcement
5paisa Capital Ltd filed its quarterly shareholding pattern under Regulation 31(1)(c). It reports routine holding figures with no new transaction or corporate event.
Axel Polymers Other Announcement
Axel Polymers reports no deviation in utilisation of its Rs 11.18 Crore preferential issue proceeds for the quarter ended 30 September 2026. This is a routine Regulation 32 statement of deviation with a clean auditor certificate.
360 One Wam Other Announcement
360 ONE WAM disclosed PIT sales by five insiders on 12 November 2026, totalling about Rs 3.55 Crore. The sellers are designated persons, KMP and an employee's relative, with no promoter involved.
- Value
- ₹3.55 Cr
Capri Global Capital Other Announcement
Capri Global Capital filed its monthly RBI ALM statement (structural liquidity and interest rate sensitivity) for October 2026, unaudited. This is a routine regulatory return with no new financing or corporate event.